What is King-Devick Test?
King-Devick Technologies, Inc., operating as King-Devick Test, specializes in developing advanced assessments and monitoring tools for eye movement disorders. Their core offerings include the proprietary King-Devick Test, a rapid assessment for eye movement impairments, and the King-Devick Reading Acceleration Program, designed to boost reading fluency and comprehension. The company serves a diverse clientele, including educational institutions, healthcare providers, and parents, with a mission to support recovery and enhance neurological function, particularly in areas such as concussion management and reading interventions. Their commitment to evidence-based solutions positions them as a key player in the health-tech and educational technology sectors.
How much funding has King-Devick Test raised?
King-Devick Test has raised a total of $399K across 2 funding rounds:
Debt
$150K
Debt
$249K
Debt (2020): $150K with participation from PPP
Debt (2021): $249K led by PPP
Key Investors in King-Devick Test
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for King-Devick Test?
As a company in a large-scale late-stage funding phase, King-Devick Test is poised for significant expansion and market penetration. The recent strategic investment suggests a focus on scaling operations, further product development, and potentially broader market outreach. This capital infusion will likely enable the company to enhance its technological capabilities, expand its research and development efforts, and strengthen its market position against competitors. The company's trajectory indicates a strategic move towards solidifying its leadership in the specialized field of eye movement disorder assessment and intervention.
See full King-Devick Test company page
